Pakistan approves China's Sinopharm vaccine for emergency use
Pakistan's drug regulatory authority has approved China's Sinopharm COVID-19 vaccine for emergency use. This comes two days after AstraZeneca's vaccine developed with Oxford University received a similar authorisation by Pakistan. The country's planning minister Asad Umar had earlier announced the decision to procure 1.1 million doses of Sinopharm vaccine.